Aronson will join Cartessa as Chief Commercial Officer to support the organization’s exponential growth.
July 28, 2020. Melville, NY – In just three years, Cartessa Aesthetics has grown to be a significant player in the aesthetics industry, eclipsing many of the long-established companies in both sales revenue and organization size. To continue to fuel this rapid growth, Cartessa Aesthetics announced today that Chris Aronson will be joining the company’s executive team as Chief Commercial Officer. In this role, Aronson will lead the strategic expansion into new verticals and support the best-in-class portfolio of products which includes the new RF Microneedling Platform VirtueRF, the CoolPeel by Tetra CO2 treatment that is reinvigorating CO2 device space and at least two more launches planned for 2020.
Aronson brings to Cartessa 20 years of sales and management experience in the medical device industry. Having joined Cynosure in 2003, Aronson held various positions in his fourteen year tenure with Cynosure including his final role as Executive Vice President of North American Sales over seeing yearly revenue in excess of $200 million, a 100+ person commercial team, and multiple product launches and company acquisitions. After leaving Cynosure, Aronson introduced the Artas iX Robot and built the North American sales force for Restoration Robotics and planned the launch the Elipse Intragastric balloon for Allurion in North America and Australia (pending FDA approval).
“This is an extremely exciting opportunity” shared Aronson. “Over the last 3 years I have been closely watching what the team at Cartessa Aesthetics and Gabe have been building and it is very impressive. The attention to every detail and the pride in which Cartessa delivers service and support to their customers is what sets them apart in a very crowded industry. It’s not about what you say, it’s about what you do, and Cartessa is delivering on their word. This is why I wanted to be a part this amazing team.”
As CCO, Aronson will once again work with Cartessa Aesthetics Founder and CEO, Gabe Lubin. “Chris and I have had great success working together in the past. His industry knowledge coupled with his strategic expertise makes him the right leader to help us achieve our mission and ambitious goals” said Lubin. Aronson will work alongside an executive team with deep marketing, operations and financial experience. Lubin added, “Our executive team reflects what Cartessa was founded to deliver – partnership and products that are unlike other aesthetic companies – and I am excited that Chris will be joining this leadership team.”
About Cartessa Aesthetics, LLC.
Cartessa Aesthetics, LLC sources leading aesthetic medical devices for distribution to dermatologists, plastic surgeons, cosmetic physicians and medical spas.
Cartessa selects the most cutting-edge technologies that offer clinically proven efficacy, patient safety, and the best possible investment for patients and professionals. Cartessa is the exclusive US partner for Quanta Systems Aesthetic Division and the company’s portfolio also includes VirtueRF, Motus AX & Motus AY, Tetra CO2 with CoolPeel and Luxea (all manufactured by DEKA), Subnovii Advanced Plasma Technology and Skinwave.